Intervention

Lipo-Dox

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions1

Lead sponsors shown2

Clinical trials

2 shown

ErbB2 Positive Metastatic Breast CancerNCT01658358 · 2012-07-01

Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast CancerNCT01451580 · 2005-09-01

Common conditions

Metastatic Breast Cancer2

Leading sponsors

China Medical University Hospital1 TTY Biopharm1

Trial status mix

TERMINATED1

UNKNOWN1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.